Showing 19,861 - 19,880 results of 103,424 for search '(( 10 ns decrease ) OR ( 5 ((fold decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.69s Refine Results
  1. 19861

    16 Weeks of Progressive Barefoot Running Training Changes Impact Force and Muscle Activation in Habitual Shod Runners by Ana Paula da Silva Azevedo (3373688)

    Published 2016
    “…A 16-week progressive barefoot running training seems to be an effective training strategy to reduce impact force, improve shock attenuation and to decrease muscle activation intensity, not only in BF running, but also in SH running, although BF condition seems to be more influenced by BF training.…”
  2. 19862
  3. 19863

    New Insights into Fish Swimming: A Proteomic and Isotopic Approach in Gilthead Sea Bream by Miguel Martin-Perez (1624459)

    Published 2012
    “…Moderate exercise enhances fish growth, although underlying physiological mechanisms are not fully known. Here we performed a proteomic and metabolic study in white (WM) and red (RM) muscle of gilthead sea bream juveniles swimming at 1.5 body lengths per second. …”
  4. 19864

    New Insights into Fish Swimming: A Proteomic and Isotopic Approach in Gilthead Sea Bream by Miguel Martin-Perez (1624459)

    Published 2012
    “…Moderate exercise enhances fish growth, although underlying physiological mechanisms are not fully known. Here we performed a proteomic and metabolic study in white (WM) and red (RM) muscle of gilthead sea bream juveniles swimming at 1.5 body lengths per second. …”
  5. 19865
  6. 19866

    Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly by Singa Wang Chiu (3383579)

    Published 2016
    “…<p>Variations of the ratio of rework and regular production rates (<i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub>) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i><sub>2i</sub>/<i>P</i><sub>1i</sub> decreases below a turning point 0.5, the expected system cost begins to increase significantly</p>…”
  7. 19867

    Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i><sub><i>k</i></sub> = 100,500,1000 (<i>kg</i>/<i>m</i><sup>2</sup> <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i><sub><i>L</i></sub> for inward protection model is 0.5. by Akshay Anand (118579)

    Published 2025
    “…<p>Contribution of the through-mask leakages from the cavity and channel network distributed along the periphery of the mask; a–c and d–f are decreasing porosity <i>c</i><sub><i>k</i></sub> = 100,500,1000 (<i>kg</i>/<i>m</i><sup>2</sup> <i>s</i>) for outward protection (with nose clips) and inward protection model, respectively; the <i>k</i><sub><i>L</i></sub> for inward protection model is 0.5.…”
  8. 19868

    Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…<p>As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. …”
  9. 19869

    Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

    Published 2023
    “…<p>As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. …”
  10. 19870

    Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

    Published 2023
    “…<p>As effective therapies for relapse and refractory B-cell acute lymphoblastic leukemia (B-ALL) remain problematic, novel therapeutic strategies are needed. Artemis is a key endonuclease in V(D)J recombination and nonhomologous end joining (NHEJ) of DNA double-strand break (DSB) repair. …”
  11. 19871
  12. 19872
  13. 19873
  14. 19874
  15. 19875

    Association and dissociation of BODIPY FL GTPγS with PfG from <i>Plasmodium</i>. by Annette Kaiser (386455)

    Published 2015
    “…The increase in fluorescence was monitored until saturation over a time interval of 600 s. Part B At the arrow at t = 200 s, 20 μM unlabeled GTPγS was added and the decrease in fluorescence was monitored. …”
  16. 19876

    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... by Lívia Pimenta Bonifácio (7502579)

    Published 2023
    “…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”
  17. 19877
  18. 19878
  19. 19879
  20. 19880